Translation, cultural adaptation and validation of the Danish version of the haematological malignancy patient-reported outcome measure (HM-PRO)
Abstract Background Assessment of cancer patients´ quality of life (QoL) through patient-reported outcomes (PRO) during and after treatment is gaining ground. The HM-PRO is the first generic Haematological Malignancy specific PRO measure for use in clinical practice and clinical trials. Such generic...
| Published in: | Journal of Patient-Reported Outcomes |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2025-04-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s41687-025-00869-2 |
